Belarusian Scientists Developed Two Drugs to Combat Lung Cancer

Belarusian scientists have developed two drugs to combat lung cancer, which have no analogues in the world today. One of them is based on a cyclopeptide. The drug has already demonstrated high efficacy in preclinical trials.

Tatyana Nevar, Deputy Director of the Institute of Physical and Organic Chemistry of the National Academy of Sciences of Belarus:

"Peptide-based drugs have poorer efficacy and side effects than many cytostatic drugs currently used for these purposes. So-called gene therapy drugs are also actively developing."

The scientists note that, over time, high-volume production of such drugs will be able not only to meet domestic needs but also for export.